TAMPA, Fla.--(BUSINESS WIRE)--Xcelience, a leader in early drug development services, recently announced the addition of Brett F. Truitt, who will serve as Team Leader, Formulation Development in the ...

Aptuit said today it has acquired Kuecept for an undisclosed price, in a deal the buyer said would help it meet customer demand for specialist drug preformulation, formulation prototyping, and ...

In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...

The Netherlands-based Ofichem Group signed a definitive agreement to acquire Avivia, another Netherlands-based company that specializes in formulation development. Ofichem officials say the ...

Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that Adrian Raiche, Ph.D. has joined the company as Director of Formulation ...

Solubility is fundamental in successfully developing all classes of therapeutic biopolymers. Contact with stressors related to mechanical stirring or changes in buffer conditions may cause ...

ALBANY, N.Y.--(BUSINESS WIRE)--Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced it has entered into a definitive agreement to acquire ...

LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers ...

Cytovance Biologics, a U.S.-based Contract Development and Manufacturing Organization (CDMO), announced the launch of its in-house formulation development services, significantly expanding its service ...

TORONTO, January 10, 2023 [Embargo 10 a.m. London Time] – Scientists at the University of Toronto have successfully tested the use of machine learning models to guide the design of long-acting ...

Clinical evaluation of several modified release once-daily formulations of danuglipron resulted in encouraging pharmacokinetic data for several candidates with one showing the most favorable profile ...